Explore how our CHO-K1 Kv11.1 (hERG) recombinant cell line was validated for use in Automated Patch Clamp (APC) electrophysiology using the SyncroPatch 384 from Nanion Technologies. This application note highlights high-throughput cardiac safety testing capabilities, pharmacological validation with known hERG inhibitors, and key electrophysiological properties
